Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cedars-Sinai Health Ventures is the strategic venture investment arm of Cedars-Sinai focused on advancing healthcare and biomedicine through technology. Rather than operating as a drug-development biotech, it invests in and helps scale external companies whose products and services may be adopted within the Cedars-Sinai health system. The organization sits within Cedars-Sinai’s broader innovation infrastructure alongside technology transfer and accelerator activities. Its investment interests span healthcare technology, digital health, medtech, and selected biotech opportunities, with an emphasis on solutions that can improve care delivery, operations, and patient outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cedars-Sinai Health Ventures.